Gain Therapeutics, Inc. (GANX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Join SI Premium – FREE
Gain Therapeutics, Inc. (NASDAQ: GANX) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15).
For earnings history and earnings-related data on Gain Therapeutics, Inc. (GANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
